Cinacalcet

🧮 Dose calculator

Secondary hyperparathyroidism in chronic kidney disease · Regimen source: FDA Sensipar · 2.2

• • Every 2–4 weeks: 30 → 60 → 90 → 120 → 180 mg to iPTH 150–300. Calcium and phosphorus within 1 week, iPTH 1–4 weeks after each change. With food; swallow whole. FDA Sensipar · 2.2FDA Sensipar · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Sensipar · 8.1

  “Risk Summary Limited case reports of Sensipar use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Sensipar · 8.2

  “Risk Summary There are no data regarding the presence of Sensipar in human milk or effects on the breastfed infant or on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Sensipar · 8.4

  “The safety and efficacy of Sensipar have not been established in pediatric patients.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Sensipar · 8.5

  “Of the total number of subjects (n = 1136) in clinical studies of Sensipar, 26 percent were 65 and over, and 9 percent were 75 and over.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.